Dr. Avy Violari, MD, FCPaed (SA)
Deputy Executive Director
Director: Paediatric Clinical Trials
Dr. Violari is a paediatrician who is the head of PHRU's paediatric division. She was the lead investigator of the CHER trial at the PHRU. CHER is a landmark study that resulted in a major change to World Health Organisation (WHO) paediatric antiretroviral therapy guidelines. Dr. Avy Violari led one of the largest and most successful prevention of mother-to-child transmission of HIV (PMTCT) programmes in Africa. She has extensive clinical trials experience in paediatric and PMTCT research with a special interest in HIV/AIDS in children, especially infants with early infection. Dr. Violari has been involved in 24 HIV/AIDS trials, acting as Principal Investigator for 6 of them. Currently, she is the Principal Investigator of the PROMISE trial at the PHRU, which is one of the largest and most ambitious PMTCT trials ever undertaken.